Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

152 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The management of localized prostate cancer.
Dawson NA, Fourcade RO, Newling D. Dawson NA, et al. Among authors: newling d. Prostate Cancer Prostatic Dis. 2002;5 Suppl 2:S3-7. doi: 10.1038/sj.pcan.4500619. Prostate Cancer Prostatic Dis. 2002. PMID: 12496989
Quality control of radical prostatectomy: a feasibility study.
Van Poppel H, Collette L, Kirkali Z, Brausi M, Hoekstra W, Newling DW, Decoster M; EORTC GU Group. Van Poppel H, et al. Among authors: newling dw. Eur J Cancer. 2001 May;37(7):884-91. doi: 10.1016/s0959-8049(01)00056-9. Eur J Cancer. 2001. PMID: 11313177 Clinical Trial.
Relative importance of PSA in prostate cancer treatment.
Unger HA, Kane RD, Fox KM, Gandhi S, Alzola C, Lamerato L, Newling D, Kumar S. Unger HA, et al. Among authors: newling d. Urol Oncol. 2005 Jul-Aug;23(4):238-45. doi: 10.1016/j.urolonc.2005.03.019. Urol Oncol. 2005. PMID: 16018938
Is prostate-specific antigen a valid surrogate end point for survival in hormonally treated patients with metastatic prostate cancer? Joint research of the European Organisation for Research and Treatment of Cancer, the Limburgs Universitair Centrum, and AstraZeneca Pharmaceuticals.
Collette L, Burzykowski T, Carroll KJ, Newling D, Morris T, Schröder FH; European Organisation for Research and Treatment of Cancer; Limburgs Universitair Centrum; AstraZeneca Pharmaceuticals. Collette L, et al. Among authors: newling d. J Clin Oncol. 2005 Sep 1;23(25):6139-48. doi: 10.1200/JCO.2005.08.156. J Clin Oncol. 2005. PMID: 16135480
Value of an Immediate Intravesical Instillation of Mitomycin C in Patients with Non-muscle-invasive Bladder Cancer: A Prospective Multicentre Randomised Study in 2243 patients.
Bosschieter J, Nieuwenhuijzen JA, van Ginkel T, Vis AN, Witte B, Newling D, Beckers GMA, van Moorselaar RJA. Bosschieter J, et al. Among authors: newling d. Eur Urol. 2018 Feb;73(2):226-232. doi: 10.1016/j.eururo.2017.06.038. Epub 2017 Jul 10. Eur Urol. 2018. PMID: 28705539 Clinical Trial.
Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies.
Brausi M, Collette L, Kurth K, van der Meijden AP, Oosterlinck W, Witjes JA, Newling D, Bouffioux C, Sylvester RJ; EORTC Genito-Urinary Tract Cancer Collaborative Group. Brausi M, et al. Among authors: newling d. Eur Urol. 2002 May;41(5):523-31. doi: 10.1016/s0302-2838(02)00068-4. Eur Urol. 2002. PMID: 12074794
152 results